PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cocaine addiction, craving and relapse

Paradigm shift in treatment of addiction holds promise, thanks to epigenetics

2015-05-27
(Press-News.org) One of the major challenges of cocaine addiction is the high rate of relapse after periods of withdrawal and abstinence. But new research reveals that changes in our DNA during drug withdrawal may offer promising ways of developing more effective treatments for addiction.

Withdrawal from drug use results in reprogramming of the genes in the brain that lead to addictive personality, say researchers from McGill University and Bar Ilan University in a new study published in the Journal of Neuroscience.

"We inherit our genes from our parents and these genes remain fixed throughout our life and are passed on to our children; we can do very little to change adverse genetics changes that we inherit," says Moshe Szyf, a professor in the Faculty of Medicine at McGill, "In contrast, epigenetic marks such as DNA methylation act as switches and dimmers of genes- they can be switched on, off, or dimmed - by epigenetic drugs inhibiting DNA methylation and removing methyl marks from these genes."

The researchers wanted to see if they could stop addictive behavior by influencing the epigenetic markers that were triggered by withdrawal using epigenetic drugs such as the DNA methylation inhibitor, RG108.

Rat model of addiction The team used a rat model of incubation of cocaine craving, in which rats were trained to self-administer cocaine which was cued by a specific light or sound. This drug craving or "addictive" behavior was tested after either 1 day or 30 days of withdrawal from cocaine. Following the long withdrawal, the rats developed an intense drug seeking behavior when exposed to the cue. It was after a lengthy period without the drugs that the epigenetic changes were most evident.

Revolutionary approach to treating drug addiction "We discovered that injecting the drug RG108 just before the animals were exposed to the light cue after the long withdrawal not only stopped the addictive behavior of the animals, it also lasted for a longer period. This suggests that a single treatment with RG108 could reverse or perhaps cure drug addiction." adds Szyf.

Period of withdrawal is key "Surprisingly, we discovered that the biggest changes in DNA methylation occurred not during the exposure to the drug but during withdrawal," says co-author Gal Yadid, of Bar Ilan University, "During this period of withdrawal, hundreds of genes changed their state of DNA methylation including genes that were known before to be involved in addiction".

This research may point to new avenues for treatment of addiction in humans.

Current treatments might aggravate rather than inhibit addiction "The mainstay of current approaches to treating addiction might actually aggravate it," says Yadid. "Our research suggests that because the changes in addiction involve numerous genes, our current approaches will continue to fail if we target one or few targets in the brain, but more research is needed to confirm if these new avenues hold promise."

INFORMATION:

The study was funded by a grant from the Canadian Institute of Health Research, grants from Ministere du Developpement Economique, de l'Innovation et de l'Exportation (MDEIE) program of the government of Quebec and the Israel Anti-Drug Authority.

"Role of DNA Methylation in the Nucleus Accumbens in Incubation of Cocaine Craving" Renaud Massart, Royi Barnea, Yahav Dikshtein, Matthew Suderman, Oren Meir, Michael Hallett, Pamela Kennedy and Eric J. Nestler. Moshe Szyf, Gal Yadid, Journal of Neuroscience



ELSE PRESS RELEASES FROM THIS DATE:

One step closer to a single-molecule device

One step closer to a single-molecule device
2015-05-26
New York, NY--May 25, 2015--Under the direction of Latha Venkataraman, associate professor of applied physics at Columbia Engineering, researchers have designed a new technique to create a single-molecule diode, and, in doing so, they have developed molecular diodes that perform 50 times better than all prior designs. Venkataraman's group is the first to develop a single-molecule diode that may have real-world technological applications for nanoscale devices. Their paper, "Single-Molecule Diodes with High On-Off Ratios through Environmental Control," is published May 25 ...

Moderate drinking in later years may damage heart

2015-05-26
DALLAS, May 26, 2015 -- Drinking two or more alcoholic beverages daily may damage the heart of elderly people, according to research in the American Heart Association journal Circulation: Cardiovascular Imaging. The study correlated weekly alcohol consumption among 4,466 people -- average age 76 -- to the size, structure and motion of various parts of the heart. Researchers found: The more people drank, the greater the subtle changes to the heart's structure and function. Among men, drinking more than 14 alcoholic beverages weekly (heavy drinking) was linked with ...

Future vaccine may help lower blood pressure long-term

2015-05-26
DALLAS, May 26, 2015 - A vaccine may one day help lower blood pressure for up to six months, according to new research in the American Heart Association's journal Hypertension. The study in rats may eventually provide a novel alternative to treat high blood pressure in people, who would not need to take a pill everyday. "The potential of a vaccine for hypertension offers an innovative treatment that could be very effective for the control of non-compliance which is one of the major problems in the management of hypertensive patients," said Hironori Nakagami M.D., ...

World first as viral immunotherapy for skin cancer shows patient benefit in phase III trial

2015-05-26
A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown. It is the first time that a phase III trial of viral immunotherapy has definitively shown benefit for patients with cancer. The trial was led in the UK by researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, and involved 64 research centres worldwide including the University of Oxford. Researchers randomised 436 patients ...

Study identifies possible role for carbon monoxide in treating hemorrhagic stroke

2015-05-26
BOSTON -- Carbon monoxide is known by many as a poisonous gas that causes brain injury and other neurological symptoms, including memory loss and confusion. But a new study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) suggests the opposite may be true: When administered in small, carefully controlled amounts, carbon monoxide may actually protect the brain from damage following subarachnoid hemorrhage, a devastating stroke that results from bleeding in the brain. Published online today in The Journal of Clinical Investigation (JCI), the new findings ...

Possible overuse of anticoagulants, PCI outcomes studied using registry data

2015-05-26
WASHINGTON (May 26, 2015) -- The American College of Cardiology's National Cardiovascular Data Registry was the source of data for seven studies published in the first four months of 2015, including a study that identified possible overuse of anticoagulants in low-risk atrial fibrillation patients and research that found a relationship between operator experience and outcomes in certain patients after percutaneous coronary intervention or angioplasty. CathPCI Registry Study Compares Outcomes of Sleep-Deprived vs. Non-Sleep-Deprived PCI Operators Only a small number of ...

Breakthrough measures Parkinson's progression in the brain

2015-05-26
University of Florida researchers have identified a biomarker that shows the progression of Parkinson's disease in the brain, opening the door to better diagnosis and treatment of the degenerative disease. By comparing brain images of Parkinson's patients to those of a control group over a year, an interdisciplinary team found that an area of the brain called the substania nigra changes as the disease advances. The findings provide the first MRI-based method to measure the disease's progression, which can inform treatment decisions and aid in identifying new therapies, ...

Season influenza vaccination of children predicted to be highly cost-effective in Thailand

2015-05-26
Seasonal influenza vaccination of children is likely to represent good short-term value for money in Thailand, according to a study published this week in PLOS Medicine. The study, led by Aronrag Meeyai of the Health Intervention and Technology Assessment Program and Mahidol University, Thailand, uses an age-structured model to estimate the health benefits and cost-effectiveness of flu vaccination among Thai children aged 2 to 17 years. Many seasonal influenza vaccination programs target elderly people, who have the highest risk of dying as a result of an influenza infection. ...

Dietary Guidelines for Americans linked to lower death rates in population in southeast US

2015-05-26
Adherence to the Dietary Guidelines for Americans (DGA) is linked to lower death rates in a low-income population in southeastern US. In a low-income population from the southeastern US, higher adherence to the Dietary Guidelines for Americans (DGA) was linked with 14%-23% lower mortality from cardiovascular disease, cancer, and other diseases, according to a study published by Wei Zheng and colleagues from Vanderbilt University, Nashville, USA, in this week's PLOS Medicine. The researchers analyzed data from the Southern Community Cohort Study (SCCS), a study including ...

Pitt team IDs two new, very large classes of RNAs linked to cancer biomarker

2015-05-26
PITTSBURGH, May 26, 2015 - Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer. Their findings were published in the June issue of the scientific journal RNA. Levels of human Y-box binding protein 1 (YB-1), which is involved in many cellular functions, have been shown to correlate with drug resistance and poor patient outcomes in a variety of cancers. The observation that ...

LAST 30 PRESS RELEASES:

Doctors received approximately $12.1 billion from drug and device makers between 2013-2022

Discovery suggests new strategy against follicular lymphoma

Making the future too bright: how wishful thinking can point us in the wrong direction

Ochsner Health named to Newsweek’s America’s Greatest Workplaces 2024 for Job Starters

Three-year study of young stars with NASA’s Hubble enters new chapter

North Carolina takes the lead in PFAs research with Collaboratory’s $3 million investment to expand the state’s research capacity

Is it the school, or the students?

Exploring the relationship between HIV pre-exposure prophylaxis and the incidence of chlamydia, gonorrhea and syphilis – findings from Denmark

Music: Song lyrics have become simpler and more repetitive since 1980

Environment: More than half of Colorado River’s water used to irrigate crops

When inequality is more than “skin-deep”: Social status leaves traces in the epigenome of spotted hyenas in Tanzania

Study explores the future of at-home cancer treatment

First performance standards published to measure the effectiveness of lifestyle medicine treatments

To keep volunteers, connect them

Suppressing boredom at work hurts future productivity, study shows

Older brain cells linger unexpectedly before their death

Clear shift in arterial diseases in diabetes

Celebrating half a century of pioneering excellence: EBMT marks its 50th anniversary

Ancient DNA reveals the appearance of a 6th century Chinese emperor

DNA study IDs descendants of George Washington from unmarked remains, findings to aid service member IDs going back to World War II

Familial Alzheimer’s disease transferred via bone marrow transplant in mice

Perspectives of oncologists on the ethical implications of using AI for cancer care

Industry payments to US physicians by specialty and product type

Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer

COVID-19 antibody discovery could explain long COVID

Wild plants face viral surprise

Storing electrons from hydrogen for clean chemical reactions

Unlocking how to use mRNA to target Alzheimer’s disease

Kessler Foundation secures $770,000 in grants to advance leading-edge spinal cord research

Going ‘back to the future’ to forecast the fate of a dead Florida coral reef

[Press-News.org] Cocaine addiction, craving and relapse
Paradigm shift in treatment of addiction holds promise, thanks to epigenetics